NO20076603L - Thrombospondin-1 derived peptides and treatment methods - Google Patents

Thrombospondin-1 derived peptides and treatment methods

Info

Publication number
NO20076603L
NO20076603L NO20076603A NO20076603A NO20076603L NO 20076603 L NO20076603 L NO 20076603L NO 20076603 A NO20076603 A NO 20076603A NO 20076603 A NO20076603 A NO 20076603A NO 20076603 L NO20076603 L NO 20076603L
Authority
NO
Norway
Prior art keywords
peptides
tsp
thrombospondin
treatment methods
derived peptides
Prior art date
Application number
NO20076603A
Other languages
English (en)
Norwegian (no)
Inventor
Ramtin Agah
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of NO20076603L publication Critical patent/NO20076603L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
NO20076603A 2005-06-24 2007-12-21 Thrombospondin-1 derived peptides and treatment methods NO20076603L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69357405P 2005-06-24 2005-06-24
PCT/US2006/024692 WO2007002534A2 (en) 2005-06-24 2006-06-23 Thrombospondin-1 derived peptides and treatment methods

Publications (1)

Publication Number Publication Date
NO20076603L true NO20076603L (no) 2008-03-17

Family

ID=37595929

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076603A NO20076603L (no) 2005-06-24 2007-12-21 Thrombospondin-1 derived peptides and treatment methods

Country Status (13)

Country Link
US (1) US8546323B2 (ru)
EP (1) EP1901761A4 (ru)
JP (1) JP2008543345A (ru)
KR (1) KR20080039878A (ru)
CN (1) CN101267829A (ru)
AU (1) AU2006261911B2 (ru)
BR (1) BRPI0613357A2 (ru)
CA (1) CA2613193A1 (ru)
EA (1) EA200800123A1 (ru)
IL (1) IL188310A0 (ru)
NO (1) NO20076603L (ru)
UA (1) UA94046C2 (ru)
WO (1) WO2007002534A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2198873A1 (en) * 2008-12-18 2010-06-23 Aposcience AG Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
EP2201954A1 (en) * 2008-12-18 2010-06-30 Aposcience AG Pharmaceutical preparation
WO2012026614A1 (ja) * 2010-08-24 2012-03-01 国立大学法人宮崎大学 マトリックスメタロプロテアーゼ活性抑制組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434593D1 (de) * 1993-08-13 2006-02-02 Uab Res Foundation Birmingham Verfahren und zusammensetzungen zur stimulation und inhibition der aktivität von tgf-beta
US6458767B1 (en) * 1994-05-04 2002-10-01 The Uab Research Foundation Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease
US7220557B2 (en) 1997-04-24 2007-05-22 Human Genome Sciences, Inc. METH1 polynucleotides
NZ516237A (en) * 1999-05-25 2004-03-26 Human Genome Sciences Inc Meth1 and meth2 polynucleotides and polypeptides
EP1325338A2 (en) * 2000-04-03 2003-07-09 Oxford GlycoSciences (UK) Limited Diagnosis and treatment of alzheimer's disease
US20030134784A1 (en) * 2000-08-17 2003-07-17 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 83P2H3 and CaTrF2E11 useful in treatment and detection of cancer
US20030166017A1 (en) 2000-11-09 2003-09-04 Millennium Pharmaceuticals, Inc. Compositions and methods for the identification, assessment, prevention and therapy of cardiovascular disease
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
DE60235413D1 (de) * 2001-12-07 2010-04-01 Novartis Vaccines & Diagnostic Bei prostatakrebs hochreguliertes endogenes retrovirus

Also Published As

Publication number Publication date
UA94046C2 (ru) 2011-04-11
WO2007002534A2 (en) 2007-01-04
WO2007002534A3 (en) 2007-12-06
CN101267829A (zh) 2008-09-17
IL188310A0 (en) 2008-04-13
EA200800123A1 (ru) 2008-12-30
CA2613193A1 (en) 2007-01-04
AU2006261911B2 (en) 2010-05-13
AU2006261911A1 (en) 2007-01-04
BRPI0613357A2 (pt) 2017-02-21
JP2008543345A (ja) 2008-12-04
EP1901761A4 (en) 2009-08-12
US20090131314A1 (en) 2009-05-21
EP1901761A2 (en) 2008-03-26
US8546323B2 (en) 2013-10-01
KR20080039878A (ko) 2008-05-07

Similar Documents

Publication Publication Date Title
Pisarewicz et al. Polypeptide chains containing d-γ-hydroxyvaline
ATE382364T1 (de) Von igf-bindungsprotein stammendes peptid
ATE482972T1 (de) Tgf-beta1-bindende und geträgerte peptide
Dekan et al. Total synthesis of human hepcidin through regioselective disulfide‐bond formation by using the safety‐catch cysteine protecting group 4, 4′‐dimethylsulfinylbenzhydryl
PE20070684A1 (es) MOLECULAS QUIMERICAS DE ANTICUERPO RANKL-PTH/PTHrP
NO20085131L (no) Lyofiliserte preparater av anti-EGFR-antistoffer
WO2006121610A3 (en) Personal care compositions and methods for their use
NZ593815A (en) Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use
ES2143780T3 (es) Compuestos que enlazan las quinasas ciclinodependientes.
ATE286051T1 (de) Sulfonamide und ihre derivate, die die aktivität des endothelins modulieren
ES2526912T3 (es) Composición farmacéutica que contiene neurotoxina botulínica A2
DK1641820T3 (da) Fra RasGap afledt peptid til selektiv at dræbe kræftceller
NO20076603L (no) Thrombospondin-1 derived peptides and treatment methods
ATE326981T1 (de) Isolierte peptide die aminosäuresequenzen von ny- eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE443076T1 (de) Von protease typ ii spaltbares peptid
WO2002012326A3 (en) Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
ES2531480T3 (es) Péptidos derivados de la proteína bplp humana, polinucleótidos que codifican dichos péptidos y anticuerpos dirigidos contra dichos péptidos
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
BRPI0606445A2 (pt) inibidores de hipersecreÇço de mucina e mÉtodos de uso
DK1204679T3 (da) Peptider som indeholder N-substituerede D-aminosyrer til at forhindre associering af Beta-strenge
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
Bardag-Gorce et al. Delta-aminolevulinic dehydratase is a proteasome interacting protein
WO2005044301A3 (en) Use of specific histones for the treatment of parasitic diseases
IL193310A0 (en) Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same
AR033570A1 (es) Procedimiento de tratamiento conveniente para la deformacion y/o el marcado, y esto, en forma permanente, de materias queratinicas, composicion cosmetica reductora lista para usar, y kits para el tratamiento conveniente para la deformacion y/o el marcado, y esto, en forma permanente, de materias que

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application